Tobi Podhaler TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: tobramycin
Brand name
(ARTG)
: TOBI PODHALER tobramycin 28 mg hard capsule for inhalation blister pack with Podhaler deviceDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
TOBI solution and TOBI Podhaler are indicated for the management of cystic fibrosis patients with P. aeruginosa infections. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with FEV1 less than or equal to 25 % or greater than or equal to 80 % predicted at screening, or patients colonized with Burkholderia cepacia. (See CLINICAL TRIALS)
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, hard
- Inhalation
- Clear, colourless capsule marked in blue with Mylan logo and "MYL TPH"
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 4 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 224 capsules + 5 Podhalers pack
- 8 capsules + 1 Podhaler pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient tobramycin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
